Product NDC: | 0075-2452 |
Proprietary Name: | DDAVP |
Non Proprietary Name: | desmopressin acetate |
Active Ingredient(s): | .1 mg/mL & nbsp; desmopressin acetate |
Administration Route(s): | NASAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0075-2452 |
Labeler Name: | sanofi-aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017922 |
Marketing Category: | NDA |
Start Marketing Date: | 19780221 |
Package NDC: | 0075-2452-01 |
Package Description: | 5 mL in 1 BOTTLE, SPRAY (0075-2452-01) |
NDC Code | 0075-2452-01 |
Proprietary Name | DDAVP |
Package Description | 5 mL in 1 BOTTLE, SPRAY (0075-2452-01) |
Product NDC | 0075-2452 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | desmopressin acetate |
Dosage Form Name | SOLUTION |
Route Name | NASAL |
Start Marketing Date | 19780221 |
Marketing Category Name | NDA |
Labeler Name | sanofi-aventis U.S. LLC |
Substance Name | DESMOPRESSIN ACETATE |
Strength Number | .1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |